{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T18:38:37Z","timestamp":1766428717431,"version":"build-2065373602"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.pcad.2021.11.008","type":"journal-article","created":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T16:22:01Z","timestamp":1637425321000},"page":"62-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Catheter based interventions for lower extremity peripheral artery disease"],"prefix":"10.1016","volume":"69","author":[{"given":"Rohan B.","family":"Parikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Victor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2021.11.008_bb0005","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2021.11.008_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","article-title":"Secondary prevention and mortality in peripheral artery disease: National Health and nutrition examination study, 1999 to 2004","volume":"124","author":"Pande","year":"2011","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2021.11.008_bb0015","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet."},{"issue":"145\u2013158","key":"10.1016\/j.pcad.2021.11.008_bb0020","article-title":"Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010","volume":"9","author":"Sampson","year":"2014","journal-title":"Glob Heart"},{"key":"10.1016\/j.pcad.2021.11.008_bb0025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","article-title":"Drug-eluting stent versus drug-coated balloon revascularization in patients with Femoropopliteal arterial disease","volume":"73","author":"Bausback","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0030","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The Framingham heart study and the epidemiology of cardiovascular disease: a historical perspective","volume":"383","author":"Mahmood","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.pcad.2021.11.008_bb0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jama.292.4.453","article-title":"Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms","volume":"292","author":"McDermott","year":"2004","journal-title":"JAMA."},{"key":"10.1016\/j.pcad.2021.11.008_bb0040","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jacc.2013.01.054","article-title":"Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects","volume":"61","author":"Savji","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1253\/circj.CJ-08-0141","article-title":"Patients with peripheral artery disease who complete 12-week supervised exercise training program show reduced cardiovascular mortality and morbidity","volume":"73","author":"Sakamoto","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.pcad.2021.11.008_bb0050","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.mayocp.2014.12.016","article-title":"Effect of physical activity assessment on prognostication for peripheral artery disease and mortality","volume":"90","author":"Chang","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pcad.2021.11.008_bb0055","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jacc.2013.01.004","article-title":"Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF\/AHA guideline recommendations): a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"61","author":"Rooke","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0060","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jacc.2015.12.049","article-title":"Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options","volume":"67","author":"Olin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0065","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrcardio.2011.91","article-title":"Arterial thrombus formation in cardiovascular disease","volume":"8","author":"Lippi","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0070","first-page":"499","article-title":"Surgical treatment of peripheral circulation disorders","volume":"21","author":"Fontaine","year":"1954","journal-title":"Helv Chir Acta"},{"key":"10.1016\/j.pcad.2021.11.008_bb0075","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.11.008_bb0080","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD). TASC working group. TransAtlantic inter-society consensus (TASC)","volume":"31","author":"Dormandy","year":"2000","journal-title":"J Vasc Surg"},{"issue":"363\u2013370","key":"10.1016\/j.pcad.2021.11.008_bb0085","article-title":"Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions","volume":"55","author":"Iida","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.11.008_bb0090","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1148\/radiol.2312020920","article-title":"Infrarenal aortic and lower-extremity arterial disease: diagnostic performance of multi-detector row CT angiography","volume":"231","author":"Catalano","year":"2004","journal-title":"Radiology."},{"key":"10.1016\/j.pcad.2021.11.008_bb0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1024\/0301-1526\/a000742","article-title":"Guiding peripheral arterial disease management with magnetic resonance imaging","volume":"48","author":"Takahashi","year":"2019","journal-title":"Vasa."},{"key":"10.1016\/j.pcad.2021.11.008_bb0100","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.CIR.81.2.602","article-title":"Benefit of exercise conditioning for patients with peripheral arterial disease","volume":"81","author":"Hiatt","year":"1990","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2021.11.008_bb0105","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/01.CIR.90.4.1866","article-title":"Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response","volume":"90","author":"Hiatt","year":"1994","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2021.11.008_bb0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/CIRCULATIONAHA.111.075770","article-title":"Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study","volume":"125","author":"Murphy","year":"2012","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2021.11.008_bb0115","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.2015.14851","article-title":"Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial","volume":"314","author":"Fakhry","year":"2015","journal-title":"JAMA."},{"key":"10.1016\/j.pcad.2021.11.008_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.11.008_bb0125","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.jcin.2014.07.012","article-title":"Critical limb ischemia and intermediate-term survival","volume":"7","author":"Beckman","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0130","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jvs.2010.01.073","article-title":"Bypass versus angioplasty in severe Ischaemia of the leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy","volume":"51","author":"Bradbury","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.11.008_bb0135","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jacc.2016.02.040","article-title":"Nationwide trends of hospital admission and outcomes among critical limb ischemia patients: from 2003-2011","volume":"67","author":"Agarwal","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.tvir.2014.08.012","article-title":"The BEST-CLI trial: a multidisciplinary effort to assess which therapy is best for patients with critical limb ischemia","volume":"17","author":"Farber","year":"2014","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0145","first-page":"28","article-title":"The father of intervention","volume":"28","author":"Payne","year":"2001","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.pcad.2021.11.008_bb0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fcvm.2014.00015","article-title":"Balloon angioplasty - The LEGACY of Andreas Gruntzig, M.D. (1939\u20131985)","volume":"1","author":"Barton","year":"2014","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pcad.2021.11.008_bb0190","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jvs.2004.02.039","article-title":"Understanding trends in inpatient surgical volume: vascular interventions, 1980-2000","volume":"39","author":"Anderson","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.11.008_bb0195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jvs.2009.01.035","article-title":"National trends in lower extremity bypass surgery, endovascular interventions, and major amputations","volume":"50","author":"Goodney","year":"2009","journal-title":"J Vasc Surg"},{"issue":"5","key":"10.1016\/j.pcad.2021.11.008_bb0200","first-page":"49","article-title":"Guidewire selection in critical limb ischemia","volume":"16","author":"Fadi Saab","year":"2017","journal-title":"Road Map to Success: Endovascular Today"},{"key":"10.1016\/j.pcad.2021.11.008_bb0205","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jvir.2009.08.019","article-title":"Paclitaxel-induced arterial wall toxicity and inflammation: part 2--long-term tissue response in a minipig model","volume":"20","author":"Stampfl","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0215","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/CIRCULATIONAHA.111.036574","article-title":"Percutaneous treatment of peripheral artery disease: novel techniques","volume":"126","author":"Schillinger","year":"2012","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2021.11.008_bb0220","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCRESAHA.116.303503","article-title":"Endovascular intervention for peripheral artery disease","volume":"116","author":"Thukkani","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2021.11.008_bb0225","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0230","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2021.11.008_bb0235","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of Femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2021.11.008_bb0240","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.116.026493","volume":"135","author":"Schroeder","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2021.11.008_bb0245","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.4244\/EIJ-D-18-00550","article-title":"Paclitaxel density and clinical efficacy of drug-coated balloon angioplasty for femoropopliteal artery disease: meta-analysis and adjusted indirect comparison of 20 randomised trials","volume":"15","author":"Cassese","year":"2019","journal-title":"EuroIntervention."},{"key":"10.1016\/j.pcad.2021.11.008_bb0250","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for Femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2021.11.008_bb0255","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","article-title":"1-year results from the RANGER II SFA randomized trial of the Ranger drug-coated balloon","volume":"14","author":"Sachar","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0260","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s00270-019-02279-6","article-title":"Drug-coated balloon angioplasty of Infrapopliteal lesions in patients with critical limb Ischaemia: 1-year results of the APOLLO trial","volume":"42","author":"Teichgraber","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0265","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/1708538120953663","article-title":"Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: an additional analysis from the AcoArt I study","volume":"29","author":"Sun","year":"2021","journal-title":"Vascular."},{"key":"10.1016\/j.pcad.2021.11.008_bb0270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1526602814564383","article-title":"Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial","volume":"22","author":"Scheinert","year":"2015","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.pcad.2021.11.008_bb0275","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/1358863X20988360","article-title":"Microcrystalline paclitaxel-coated balloon for revascularization of femoropopliteal artery disease: three-year outcomes of the randomized BIOPAC trial","volume":"26","author":"Nowakowski","year":"2021","journal-title":"Vasc Med"},{"key":"10.1016\/j.pcad.2021.11.008_bb0280","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00270-018-1940-1","article-title":"Two-year clinical outcomes of the CONSEQUENT trial: can Femoropopliteal lesions be treated with sustainable clinical results that are economically sound?","volume":"41","author":"Albrecht","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0285","doi-asserted-by":"crossref","first-page":"e1633","DOI":"10.4244\/EIJ-D-19-00292","article-title":"Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial","volume":"15","author":"Teichgraber","year":"2020","journal-title":"EuroIntervention."},{"key":"10.1016\/j.pcad.2021.11.008_bb0290","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jcin.2016.04.012","article-title":"Paclitaxel-eluting balloon versus standard balloon angioplasty in in-stent restenosis of the superficial femoral and proximal popliteal artery: 1-year results of the PACUBA trial","volume":"9","author":"Kinstner","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0295","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0300","first-page":"207","article-title":"The \u201cDEBELLUM\u201d--lower limb multilevel treatment with drug eluting balloon--randomized trial: 1-year results","volume":"55","author":"Fanelli","year":"2014","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.pcad.2021.11.008_bb0305","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/CIRCULATIONAHA.115.017364","article-title":"Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: the randomized femoral artery in-stent restenosis (FAIR) trial","volume":"132","author":"Krankenberg","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2021.11.008_bb0310","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/1526602820948240","article-title":"Three-year results of the IN.PACT SFA Japan trial comparing drug-coated balloons with percutaneous transluminal angioplasty","volume":"27","author":"Soga","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.pcad.2021.11.008_bb0315","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006321","article-title":"ISAR-PEBIS (paclitaxel-eluting balloon versus conventional balloon angioplasty for in-stent restenosis of superficial femoral artery): a randomized trial","volume":"6","author":"Ott","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2021.11.008_bb0320","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0325","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1583\/05-1704.1","article-title":"Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial","volume":"13","author":"Duda","year":"2006","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.pcad.2021.11.008_bb0330","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the Femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2021.11.008_bb0335","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/1526602816650206","article-title":"Twelve-month results from the MAJESTIC trial of the eluvia paclitaxel-eluting stent for treatment of obstructive Femoropopliteal disease","volume":"23","author":"Muller-Hulsbeck","year":"2016","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.pcad.2021.11.008_bb0340","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1007\/s00270-017-1771-5","article-title":"Long-term results from the MAJESTIC trial of the eluvia paclitaxel-eluting stent for Femoropopliteal treatment: 3-year follow-up","volume":"40","author":"Muller-Hulsbeck","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0345","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(18)32262-1","article-title":"A polymer-coated, paclitaxel-eluting stent (eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial","volume":"392","author":"Gray","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.pcad.2021.11.008_bb0350","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00270-020-02693-1","article-title":"Two-year efficacy and safety results from the IMPERIAL randomized study of the eluvia polymer-coated drug-eluting stent and the Zilver PTX polymer-free drug-coated stent","volume":"44","author":"Muller-Hulsbeck","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0355","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jvs.2011.01.047","article-title":"First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease","volume":"54","author":"Lammer","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.11.008_bb0360","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jacc.2009.11.072","article-title":"Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing amputations using drug eluting StEnts) trial","volume":"55","author":"Feiring","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0365","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/1755-5922.12159","article-title":"Metallic Limus-eluting stents Abluminally coated with biodegradable polymers: angiographic and clinical comparison of a novel ultra-thin Sirolimus stent versus Biolimus stent in the DESTINY randomized trial","volume":"33","author":"Lemos","year":"2015","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.pcad.2021.11.008_bb0370","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","article-title":"Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial","volume":"60","author":"Rastan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0375","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002376","article-title":"Percutaneous transluminal angioplasty and drug-eluting stents for Infrapopliteal lesions in critical limb ischemia (PADI) trial","volume":"9","author":"Spreen","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0380","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jcin.2019.12.028","article-title":"A polymer-free paclitaxel-eluting stent versus a bare-metal stent for De novo Femoropopliteal lesions: the BATTLE trial","volume":"13","author":"Goueffic","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0385","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the Femoropopliteal artery of the leg: a systematic review and Meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2021.11.008_bb0390","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ahj.2020.10.070","article-title":"Important considerations for trials for peripheral arterial disease: lessons learned from the paclitaxel mortality signal: a report on behalf of the registry assessment for peripheral interventional devices (RAPID) paclitaxel pathways program","volume":"232","author":"Lottes","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2021.11.008_bb0395","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCINTERVENTIONS.111.967794","article-title":"Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel?","volume":"5","author":"Speck","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0400","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000117","article-title":"Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing","volume":"1","author":"Granada","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.pcad.2021.11.008_bb0405","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1526602820904783","article-title":"Mortality after paclitaxel-coated device use in patients with chronic limb-threatening ischemia: a systematic review and Meta-analysis of randomized controlled trials","volume":"27","author":"Dinh","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.pcad.2021.11.008_bb0410","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejvs.2019.10.002","article-title":"Editor\u2019s choice - drug coated balloon angioplasty vs. standard percutaneous transluminal angioplasty in below the knee peripheral arterial disease: a systematic review and Meta-analysis","volume":"59","author":"Ipema","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.pcad.2021.11.008_bb0415","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of Survival with Femoropopliteal Artery Revascularization with Drug-Coated Devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0420","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ejvs.2019.12.034","article-title":"Editor\u2019s choice - long term survival after Femoropopliteal artery revascularisation with paclitaxel coated devices: a propensity score matched cohort analysis","volume":"59","author":"Behrendt","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.pcad.2021.11.008_bb0425","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcin.2015.09.035","article-title":"Zilver PTX post-market surveillance study of paclitaxel-eluting stents for treating Femoropopliteal artery disease in Japan: 12-month results","volume":"9","author":"Yokoi","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0430","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004877","article-title":"Long-term follow-up of the PADI trial: percutaneous transluminal angioplasty versus drug-eluting stents for Infrapopliteal lesions in critical limb ischemia","volume":"6","author":"Spreen","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2021.11.008_bb0435","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jcin.2019.10.059","article-title":"The IN.PACT DEEP clinical drug-coated balloon trial: 5-year outcomes","volume":"13","author":"Zeller","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0440","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jvs.2011.06.097","article-title":"A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease","volume":"54","author":"Mwipatayi","year":"2011","journal-title":"J Vasc Surg"},{"issue":"83\u201394","key":"10.1016\/j.pcad.2021.11.008_bb0445","article-title":"Durability of the balloon-expandable covered versus bare-metal stents in the covered versus balloon expandable stent trial (COBEST) for the treatment of aortoiliac occlusive disease","volume":"64","author":"Mwipatayi","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.11.008_bb0450","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ejvs.2015.06.112","article-title":"Editor\u2019s choice\u2014first results of the covered endovascular reconstruction of the aortic bifurcation (CERAB) technique for aortoiliac occlusive disease","volume":"50","author":"Grimme","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.pcad.2021.11.008_bb0455","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ejvs.2019.09.411","article-title":"Results of the covered endovascular repair of the aortic bifurcation (CERAB) technique with BeGraft balloon expandable covered stent for endovascular treatment of complex Aortoiliac lesions","volume":"58","author":"Kruszyna","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.pcad.2021.11.008_bb0460","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.113.000937","article-title":"Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: twelve-month results of the SUPERB trial","volume":"8","author":"Garcia","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0465","first-page":"115","article-title":"Technique optimization of orbital atherectomy in calcified peripheral lesions of the lower extremities: the CONFIRM series, a prospective multicenter registry","volume":"83","author":"Das","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0470","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/1526602820935611","article-title":"Three-year outcomes of orbital Atherectomy for the endovascular treatment of Infrainguinal claudication or chronic limb-threatening ischemia","volume":"27","author":"Giannopoulos","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.pcad.2021.11.008_bb0475","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1583\/09-2826.1","article-title":"One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial","volume":"16","author":"Zeller","year":"2009","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.pcad.2021.11.008_bb0480","first-page":"135","article-title":"Atherectomy in peripheral artery disease: a review","volume":"29","author":"Bhat","year":"2017","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/05-1674.1","article-title":"Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial","volume":"13","author":"Laird","year":"2006","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.pcad.2021.11.008_bb0490","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcin.2014.09.009","article-title":"Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer laser randomized controlled study for treatment of FemoropopliTEal in-stent restenosis)","volume":"8","author":"Dippel","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0495","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jcin.2021.04.010","article-title":"Intravascular lithotripsy for peripheral artery calcification: 30-day outcomes from the randomized disrupt PAD III trial","volume":"14","author":"Tepe","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0500","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/1526602818783989","article-title":"Safety and feasibility of intravascular lithotripsy for treatment of below-the-knee arterial Stenoses","volume":"25","author":"Brodmann","year":"2018","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.pcad.2021.11.008_bb0505","first-page":"335","article-title":"Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: results of disrupt PAD II","volume":"93","author":"Brodmann","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0510","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12928-013-0203-y","article-title":"Imaging or trusting on surface anatomy? A comparison between fluoroscopic guidance and anatomic landmarks for femoral artery access in diagnostic cardiac catheterization. A randomized control trial","volume":"29","author":"Chinikar","year":"2014","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.pcad.2021.11.008_bb0515","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jcin.2010.04.015","article-title":"Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (femoral arterial access with ultrasound trial)","volume":"3","author":"Seto","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0520","first-page":"1379","article-title":"Micropuncture technique for femoral access is associated with lower vascular complications compared to standard needle","volume":"97","author":"Ben-Dor","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0525","first-page":"407","volume":"88","author":"Naidu","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0530","first-page":"835","article-title":"Mastering the antegrade femoral artery access in patients with symptomatic lower limb ischemia: learning curve, complications, and technical tips and tricks","volume":"68","author":"Biondi-Zoccai","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.008_bb0535","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/01.RVI.0000096764.74047.21","article-title":"Simultaneous antegrade and retrograde access for subintimal recanalization of peripheral arterial occlusion","volume":"14","author":"Spinosa","year":"2003","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.pcad.2021.11.008_bb0540","doi-asserted-by":"crossref","first-page":"73","DOI":"10.14797\/mdcj-9-2-73","article-title":"Retrograde pedal\/tibial artery access for treatment of infragenicular arterial occlusive disease","volume":"9","author":"El-Sayed","year":"2013","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.pcad.2021.11.008_bb0545","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jvs.2017.03.430","article-title":"Radial artery access for peripheral endovascular procedures","volume":"66","author":"Kumar","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.11.008_bb0550","first-page":"392","article-title":"Re-entry devices in the treatment of peripheral chronic occlusions","volume":"38","author":"Smith","year":"2011","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.pcad.2021.11.008_bb0555","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/1526602815594249","article-title":"Targeted true lumen re-entry with the outback catheter: accuracy, success, and complications in 100 peripheral chronic Total occlusions and systematic review of the literature","volume":"22","author":"Kitrou","year":"2015","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.pcad.2021.11.008_bb0560","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jvs.2017.01.032","article-title":"Distal embolization during lower extremity endovascular interventions","volume":"66","author":"Ochoa Chaar","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.11.008_bb0565","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.avsg.2020.06.014","article-title":"The use of embolic protection devices during lower extremity peripheral vascular interventions","volume":"69","author":"Ochoa Chaar","year":"2020","journal-title":"Ann Vasc Surg"},{"issue":"1151\u20131159","key":"10.1016\/j.pcad.2021.11.008_bb0570","article-title":"Current status and future perspectives of bioresorbable stents in peripheral arterial disease","volume":"64","author":"van Haelst","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2021.11.008_bb0575","first-page":"172","article-title":"The DETOUR procedure: no more need for conventional bypass surgery?","volume":"59","author":"Krievins","year":"2018","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.pcad.2021.11.008_bb0155","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/01.CIR.30.5.654","article-title":"Transluminal treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application","volume":"30","author":"Dotter","year":"1964","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2021.11.008_bb0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1148\/radiology.156.1.3159043","article-title":"Expandable intraluminal graft: a preliminary study. Work in progress","volume":"156","author":"Palmaz","year":"1985","journal-title":"Radiology"},{"key":"10.1016\/j.pcad.2021.11.008_bb0165","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa061254","article-title":"Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"355","author":"Scheller","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2021.11.008_bb0170","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1055\/s-2008-1066752","article-title":"Excimer laser angioplasty in arterial obstructive disease. Clinical experience with guidewire-controlled catheter systems","volume":"114","author":"Werner","year":"1989","journal-title":"Dtsch Med Wochenschr"},{"issue":"2502\u20132510","key":"10.1016\/j.pcad.2021.11.008_bb0175","first-page":"2511","article-title":"Percutaneous recanalization after chronic arterial occlusion with a new dilator-catheter (modification of the Dotter technique) (author\u2019s transl)","volume":"99","author":"Gruntzig","year":"1974","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.pcad.2021.11.008_bb0180","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/BF01721041","article-title":"Percutaneous atherectomy in iliac, femoral and popliteal arteries","volume":"65","author":"Hofling","year":"1987","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.pcad.2021.11.008_bb0185","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/01.CIR.103.2.192","article-title":"Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study","volume":"103","author":"Sousa","year":"2001","journal-title":"Circulation."}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062021001274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062021001274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:19:22Z","timestamp":1758500362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062021001274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":115,"alternative-id":["S0033062021001274"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2021.11.008","relation":{},"ISSN":["0033-0620"],"issn-type":[{"type":"print","value":"0033-0620"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catheter based interventions for lower extremity peripheral artery disease","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2021.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}